Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Liver and rheumatism].

C Wiegard1, A W Lohse

  • 1I. Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.

Zeitschrift Fur Rheumatologie
|March 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High vaccination coverage and infection rate result in a robust SARS-CoV-2-specific immunity in the majority of liver cirrhosis and transplant patients: A single-center cross-sectional study.

United European gastroenterology journal·2024
Same author

Stress fractures in systemic lupus erythematosus after long-term MTX use successfully treated by MTX discontinuation and individualized bone-specific therapy.

Lupus·2019
Same author

Dynamic changes of circulating miRNAs induced by the Ebola virus vaccine VSV-EBOV.

Vaccine·2018
Same author

Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.

European radiology·2018
Same author

Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.

Alimentary pharmacology & therapeutics·2018
Same author

Lack of evidence for human serum albumin as major source of HEV infections.

Transfusion medicine (Oxford, England)·2018
Same journal

[Prevention strategies in rheumatoid arthritis : From primary prevention to targeted drug interception].

Zeitschrift fur Rheumatologie·2026
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
See all related articles

Elevated liver enzymes are common in rheumatic disease patients due to medications. Rare independent liver diseases can impact treatment, sometimes requiring liver-focused therapy before immunosuppression.

Area of Science:

  • Rheumatology
  • Hepatology
  • Clinical Medicine

Context:

  • Rheumatic diseases and liver involvement share complex relationships.
  • Elevated liver enzymes are frequently observed in patients with rheumatic conditions, often linked to immunosuppressive drugs or non-steroidal anti-inflammatory drugs (NSAIDs).
  • Drug toxicity and allergic reactions are the primary causes of elevated liver enzymes.

Purpose:

  • To explore the significance of underlying liver diseases in patients with rheumatic disorders.
  • To differentiate between drug-induced liver injury and independent liver conditions.
  • To determine how co-existing liver diseases influence the management of rheumatic diseases.

Summary:

  • While liver involvement is rare in rheumatic diseases, elevated liver enzymes are common, usually due to medication side effects.

Related Experiment Videos

  • In rare instances, independent liver diseases may coexist with rheumatic disorders, necessitating careful evaluation.
  • Identifying underlying liver conditions is crucial as they can alter treatment strategies, potentially requiring hepatological therapy before immunosuppression.

    • Impact:

    • Highlights the importance of evaluating for independent liver diseases in rheumatic patients presenting with elevated liver enzymes.
    • Emphasizes that specific hepatological treatment may be required before initiating immunosuppressive therapy for rheumatic conditions.
    • Informs clinical decision-making regarding the management of rheumatic diseases when liver abnormalities are present.